Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities

被引:26
作者
Ding, Jiaoli [1 ]
Liu, Jing [2 ]
Zhang, Zhipeng [1 ]
Guo, Jie [1 ]
Cheng, Maojun [1 ]
Wan, Yang [1 ]
Wang, Rikang [1 ]
Fang, Yuanying [1 ]
Guan, Zhiyu [2 ]
Jin, Yi [1 ]
Xie, Sai-Sai [1 ]
机构
[1] Jiangxi Univ Tradit Chinese Med, Natl Pharmaceut Engn Ctr Solid Preparat Chinese H, Nanchang 330006, Jiangxi, Peoples R China
[2] Jiangxi Univ Tradit Chinese Med, Sch Pharm, Nanchang 330006, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Histone deacetylase; Coumarin; N-hydroxycinnamamide; Antiproliferative activity; Inhibitors; HDAC INHIBITORS; IN-VITRO; CELL-DEATH; APOPTOSIS; AGENTS;
D O I
10.1016/j.bioorg.2020.104023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of novel coumarin-based N-hydroxycinnamamide derivatives were designed and synthesized as histone deacetylase (HDAC) inhibitors. Most of the synthesized compounds showed potent HDAC inhibitory activity and significant antiproliferative activity against human cancer cell lines MCF-7, HepG2, HeLa and HCT-116. Among them, compound 14f displayed the most potent HDAC inhibition, especially against HDAC1 with IC50 value of 0.19 mu M, which was better than that of SAHA (IC50 = 0.23 mu M). It also showed the strongest antiproliferative activity towards HeLa cells and more than 26-fold selectivity for HDAC1 compared with HDAC6. Molecular docking studies revealed the possible binding modes of compound 14f into the two isoforms and provided a reasonable explanation for the selectivity. In addition, compound 14f could inhibit colony formation, upregulate the acetylation level of histone H3, and induce apoptosis and cell cycle arrest at G2/M phase in HeLa cells. Taken together, these results highlighted that compound 14f might be a promising HDAC inhibitor for cancer therapy.
引用
收藏
页数:14
相关论文
共 43 条
[1]   Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents [J].
Abdizadeh, Tooba ;
Kalani, Mohammad Reza ;
Abnous, Khalil ;
Tayarani-Najaran, Zahra ;
Khashyarmanesh, Bibi Zahra ;
Abdizadeh, Rahman ;
Ghodsi, Razieh ;
Hadizadeh, Farzin .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 132 :42-62
[2]   Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents [J].
An, Ran ;
Hou, Zhuang ;
Li, Jian-Teng ;
Yu, Hao-Nan ;
Mou, Yan-Hua ;
Guo, Chun .
MOLECULES, 2018, 23 (09)
[3]   Inside HDAC with HDAC inhibitors [J].
Bertrand, Philippe .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (06) :2095-2116
[4]   Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies [J].
Brindisi, Margherita ;
Senger, Johanna ;
Cavella, Caterina ;
Grillo, Alessandro ;
Chemi, Giulia ;
Gemma, Sandra ;
Cucinella, Dora Mariagrazia ;
Lamponi, Stefania ;
Sarno, Federica ;
Iside, Concetta ;
Nebbioso, Angela ;
Novellino, Ettore ;
Shaik, Tajith Baba ;
Romier, Christophe ;
Herp, Daniel ;
Jung, Manfred ;
Butini, Stefania ;
Campiani, Giuseppe ;
Altucci, Lucia ;
Brogi, Simone .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 157 :127-138
[5]   Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy [J].
Carew, Jennifer S. ;
Giles, Francis J. ;
Nawrocki, Steffan T. .
CANCER LETTERS, 2008, 269 (01) :7-17
[6]   Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors [J].
Cheng, Chunhui ;
Yun, Fan ;
He, Jie ;
Ullah, Sadeeq ;
Yuan, Qipeng .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 173 :185-202
[7]  
Chuang JY, 2007, IN VIVO, V21, P1003
[8]   Histone acetyl transferases as emerging drug targets [J].
Dekker, Frank J. ;
Haisma, Hidde J. .
DRUG DISCOVERY TODAY, 2009, 14 (19-20) :942-948
[9]   Current developments of coumarin-based anti-cancer agents in medicinal chemistry [J].
Emami, Saeed ;
Dadashpour, Sakineh .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 102 :611-630
[10]   Current Perspectives in the Application of Medicinal Plants Against Cancer: Novel Therapeutic Agents [J].
Gezici, Sevgi ;
Sekeroglu, Nazim .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (01) :101-111